Organometallics
Article
(4-COOMe-C6H4O)P(i-Pr)2 (1d). The procedure described above
for the preparation of 1e was used here to give 1d as a colorless oil
(0.90 g, 87%). 1H NMR (400 MHz, 20 °C, CDCl3): δ 1.04−1.09 (m,
6H, CH(CH3)2), 1.11−1.15 (m, 6H, CH(CH3)2), 1.92 (m, 2H,
PCH(CH3)2), 3.85 (m, 3H, OMe), 7.13 (m, 2H, HAr), 7.94 (m, 2H,
HAr). 31P{1H} NMR (162 MHz, 20 °C, CDCl3): δ 150.4 (s). 13C{1H}
NMR (101 MHz, 20 °C, CDCl3): δ 17.01 (d, JCP = 8.32, 2C, CH3),
17.71 (d, JCP = 20.20, 2C, CH3), 28.37 (d, JCP = 17.81, 2C,
PCH(CH3)2), 51.90 (s, 1C, OMe), 118.15 (d, JPC = 11.13 2C, CHAr),
123.40 (s, 1C, CAr), 131.5 (s, 2C, CHAr), 163.48 (d, JPC = 8.42, 1C,
CO or CArOP), 166.84 (s, 1C, CO or CArOP). Anal. Calcd for
C14H21O3P (268.29): C, 62.67; H, 7.89. Found: C, 62.59; H, 7.91.
trans-{i-Pr2P(OPh)}2NiBr2 (2a). [(i-PrCN)NiBr2]n (1.9 mmol, 547
mg) was added to a solution of 1a (3.81 mmol, 800 mg) in toluene (5
mL), and the resulting brown solution was stirred for 2 h at room
temperature. Filtration and evaporation gave the target compound as a
dark brown solid (995 mg, 82%). Brown single crystals were obtained
through slow crystallization in toluene (2 days at −37 °C). This
complex is fairly air stable over short periods, but aerobic
decomposition sets in after 1 week to give an NMR-silent beige
trans-(κ2P,C-i-Pr2POPh)(i-Pr2POPh)NiBr (3a). [(i-PrCN)NiBr2]n
(1.25 mmol, 360 mg) and NEt3 (1.66 mmol, 232 μL) were added to a
solution of 1a (500 mg, 2.08 mmol) in toluene (20 mL). The resulting
brown solution was stirred over 48 h at 100 °C and evaporated, and
the solid residues were extracted with toluene (2 × 30 mL).
Evaporation of the combined extracts gave 3a as a yellow solid (540
mg, 93%), which was found to be greater than 98% pure by NMR
spectroscopy; this material was used in subsequent experiments
without further purification. Single crystals were obtained from a
1
saturated hexane solution at −37 °C. H NMR (400 MHz, 20 °C,
C6D6): δ 1.27 (vt, JHP = JHH = 6.35, 6H, CH(CH3)2), 1.30 (dd, JHP
=
4.56, JHH = 7.03, 6H, CH(CH3)2), 1.51 (dd, JHP = 16.84, JHH = 7.21,
6H, CH(CH3)2), 1.56 (dd, JHP = 16.03, JHH = 7.35, 6H, CH(CH3)2),
2.49 (m, 2H, PCH(CH3)2), 2.81 (m, 2H, PCH(CH3)2), 6.51 (t, JHH
=
7.47, 1H, HAr), 6.67 (t, JHH = 7.40, 1H, HAr), 6.80−6.87 (m, 2H, HAr),
6.93 (t, JHH = 7.65, 2H, HAr), 7.57 (d, JHH = 8.49, 2H, HAr), 7.64 (d,
JHH = 7.76, 1H, HAr). 13C{1H} NMR (101 MHz, 20 °C, CDCl3): δ
17.12 (s, 2C, CH3), 17.87 (s, 2C, CH3), 18.79 (d, JCP = 3.58, 2C,
CH3), 20.52 (d, JCP = 4.68, 2C, CH3), 28.63 (dd, JCP = 2.47, JCP
=
23.79, 2C, PCH(CH3)2), 29.94 (dd, JCP = 2.82, JCP = 17.61, 2C,
PCH(CH3)2), 110.35 (d, JPC =13.53, 1C, CHAr), 120.0 (d, JCP = 6.14,
2C, CHAr), 120.55 (m, 1C, CHAr), 122.51 (s, CHAr), 126.46 (s, 1C,
CHAr), 128.91 (s, 2C, CHAr), 132.0 (dd, JCP = 14.30, JCP = 29.37, 1C,
Ni-CAr), 142.25 (d, JCP = 11.04, 1C, CHAr), 154.73 (d, JCP = 4.62, 1C,
OCAr), 168.38 (dd, JCP = 4.33, JCP = 16.24, 1C, OCAr). 31P{1H} NMR
(162 MHz, 20 °C, C6D6): δ 151.86 (d (AB), JPP = 325, 1P), 184.66 (d
(AB), JPP = 325, 1P). Anal. Calcd for C24H37BrNiO2P2 (558.09): C,
51.65; H, 6.68. Found: C, 51.94; H, 6.71.
1
powder. H NMR (500 MHz, 20 °C, CD2Cl2): δ 1.42 (d, JHH = 7.15,
12H, CH(CH3)), 1.54 (d, JHH = 7.29, 12H, CH(CH3)), 2.79 (h, JHH
=
7.19 4H, CH(CH3)), 7.11 (tt, JHH = 7.15, JHH = 1.02 2H, Hpara), 7.37
(dd, JHH = 8.64, JHH = 7.41, 4H, Hmeta), 7.66 (dm, JHH = 7.69, 4H,
Hortho). 1H NMR (500 MHz, −68 °C, CD2Cl2): δ 1.37 (dtv, JHH = 7.25,
JHP = 7.17, 12H, CH(CH3)), 1.47 (dtv, JHH = 7.83, JHP = 7.75, 12H,
CH(CH3)), 2.70 (m, 4H, CH(CH3)), 7.10 (t, JHH = 7.37, 2H, Hpara),
7.37 (dd, JHH = 8.3, JHH = 7.66, 4H, Hmeta), 7.66 (d, JHH = 8.01, 4H,
Hortho). 13C{1H} NMR(125 MHz, 20 °C, CD2Cl2): δ 18.25 (s, 4C,
CH3), 19.70 (s, 4C, CH3), 30.08 (s, 4C, PCH(CH3)2), 120.23 (s, 4C,
CHAr), 122.96 (s, 2C, CHAr), 129.30 (s, 4C, CHAr), 155.28 (s, 2C,
CArOP). 13C{1H} NMR (125 MHz, −68 °C, CD2Cl2): δ 17.63 (s, 4C,
CH3), 19.12 (s, 4C, CH3), 29.03 (vt, JPC = 11.95, 4C, PCH(CH3)2),
119.20 (s, 4C, CHAr), 122.26 (s, 2C, CHAr), 128.80 (s, 4C, CHAr),
154.26 (s, 1C, CArOP). 31P {1H} NMR (201 MHz, 20 °C, CD2Cl2) ; δ
135.8 (bs, 1P). 31P{1H} NMR (201 MHz, −68 °C, CD2Cl2): δ 136.2
(s, 1P). Anal. Calcd for C24H38Br2NiO2P2 (639.01): C, 45.11; H, 5.99.
Found: C, 45.19; H, 5.92.
[(κ2P,C-i-Pr2POPh)NiBr(μ-Br)]2, (4a). [(i-PrCN)NiBr2]n (5.45 g,
19 mmol) and NEt3 (2.64 mL, 19 mmol) were added to a solution of
1a (2 g, 9.5 mmol) in toluene (50 mL). The resulting brown solution
was stirred over 40 h at 100 °C to give a green mixture, which was
evaporated, and the solid residues were extracted with toluene (2 × 50
mL). The extracted solution was once again evaporated to dryness and
washed with hexane (25 mL) to give 4a as a yellow powder (2.3 g,
70%). Single crystals were obtained from a saturated toluene/hexane
solution at −37 °C. 1H NMR (500 MHz, 20 °C, CD2Cl2): δ 1.37 (dd,
JHH = 6.80, JHP = 14.60, 24H, CH(CH3)), 1.57 (dd, JHH = 6.00, JHP
=
trans-{i-Pr2P(4-OMe-C6H4O)}2NiBr2 (2b). The procedure de-
scribed above for the preparation of 2a was used to give 2b as a
dark orange solid (458 mg, 80%). 1H NMR (400 MHz, 20 °C,
CDCl3): δ 1.42 (m, 24H, CH(CH3)), 2.81 (m, 4H, CH(CH3)), 3.82
(s, 6H, OMe), 6.88 (m, 4H, HAr), 7.51 (m, 4H, HAr). 13C{1H} NMR
(101 MHz, 20 °C, CDCl3): δ 18.13 (s, 4C, CH3), 19.43 (s, 4C, CH3),
29.73 (s, 4C, PCH(CH3)2), 55.63 (s, 2C, OMe), 114.02 (s, 4C, CHAr),
120.82 (s, 4C, CHAr), 148.73 (s, 2C, OCAr), 155.07 (s, 2C, CArOP).
31P{1H} NMR (162 MHz, 20 °C, CDCl3): δ 136.0 (bs, 1P). Anal.
Calcd for C26H42Br2NiO4P2 (699.06): C, 44.67; H, 6.06. Found: C,
44.71; H, 6.14.
17.37, 24H, CH(CH3)), 2.35 (m, 4H, CH(CH3)), 6.59 (m, 4H, HAr),
6.92 (m, 2H, HAr), 7.27 (m, 2H, HAr). 13C{1H} NMR (125 MHz, 20
°C, CD2Cl2): δ 16.69 (s, 4C, CH3), 18.00 (s, 4C, CH3), 28.90 (d, JCP
=
26.60, 4C, PCH(CH3)2), 110.23 (d, JCP = 13.88, 2C, CHAr), 121.02 (s,
2C, CHAr), 126.95 (s, 2C, CHAr), 128.56 (bm, 2C, NiCAr), 140.71 (s,
2C, CHAr), 166.58 (d, JCP = 12.02, 2C, OCAr). 31P{1H} NMR (201
MHz, 20 °C, CD2Cl2): δ 199.1 (s, 1P). Anal. Calcd for
C24H36Br2Ni2O2P2 (695.68): C, 41.44; H, 5.22. Found: C, 42.06; H,
5.22.
Functionalization of Phenol to 2-Benzylphenol. Benzyl
bromide (2.84 mmol, 338 μL) was added to a solution of 4a (0.95
mmol, 660 mg) in toluene (25 mL), and the resulting mixture was
stirred for 36 h at 90 °C. The final mixture was added to HClaq (100
mL, 2.5 M) and extracted with CH2Cl2 (3 × 50 mL). The combined
organic phases were dried over MgSO4, filtered, and evaporated under
vacuum, and the residue obtained was purified on a silica gel column
(CHCl3/hexane 1/1) to give 2-benzylphenol (Rf = 0.1) as a white
solid (47%, 164 mg). 1H NMR (400 MHz, 20 °C, CDCl3): δ 3.91 (s,
2H, CH2), 4.83 (s, 1H, OH), 6.63 (d, JHH = 7.81, 1H, CHAr), 6.82 (t,
JHH = 7.14, 1H, CHAr), 7.03 (m, 2H, CHAr), 7.14−7.21 (m, 5H, CHAr).
13C NMR (125 MHz, 20 °C, CDCl3): δ 36.31 (s, 1C, CH2), 115.80 (s,
1C, CHAr), 121.06 (s, 1C, CHAr), 126.38 (s, 1C, CHAr), 127.18 (s, 1C,
Cq), 127.86 (s, 1C, CHAr), 128.68 (s, 2C, CHAr), 128.80 (s, 2C, CHAr),
131.04 (s, 1C, CHAr), 140.03 (s, 1C, Cq), 153.66 (s, 1C, Cq). GC-MS:
m/z 184 (M+).
Crystal Structure Determinations. The crystallographic data for
compounds 2a,e and 3a were collected on a Bruker Microstar
generator (micro source) equipped with Helios optics, a Kappa
Nonius goniometer, and a Platinum135 detector. The crystallographic
data for complexes 4a and 2c,d were collected on a a Bruker APEX II
instrument equipped with a Incoatec I\muS Microsource and a Quazar
MX monochromator. Cell refinement and data reduction were done
trans-{i-Pr2P(4-Me-C6H4O)}2NiBr2 (2c). The procedure described
above for the preparation of 2a was used to give 2c as a dark orange
solid (800 mg, 80%). 1H NMR (400 MHz, 20 °C, CDCl3): δ 1.40 (d,
JHH = 7.06, 12H, CH(CH3)), 1.52 (d, JHH = 7.19, 12H, CH(CH3)),
2.33 (s, 6H, Me), 2.75 (h, JHH = 7.12 4H, CH(CH3)), 7.11 (d, JHH
=
8.19, 4H, HAr), 7.50 (d, JHH = 8.39, 4H, Hortho). 31P{1H} NMR (162
MHz, 20 °C, CDCl3): δ 136.0 (bs, 1P). Anal. Calcd for
C26H42Br2NiO2P2 (667.06): C, 46.81; H, 6.35. Found: C, 47.08; H,
6.44.
trans-{i-Pr2P(4-COOMe-C6H4O)}2NiBr2 (2d). The procedure
described above for the preparation of 2a was used to give 2d as a
dark orange solid (504 mg, 91%). 1H NMR (300 MHz, 20 °C,
CDCl3): δ 1.40 (d, JHH = 6.43, 12H, CH(CH3)), 1.55 (d, JHH = 6.41,
12H, CH(CH3)), 2.76 (h, JHH = 7.13 4H, CH(CH3)), 3.92 (s, 6H,
OMe), 7.63 (d, JHH = 7.63, 4H, HAr), 8.04 (d, JHH = 8.67, 4H, Hortho).
13C{1H} NMR (75 MHz, 20 °C, CDCl3): δ 18.20 (s, 4C, CH3), 19.70
(s, 4C, CH3), 29.90 (s, 4C, PCH(CH3)2), 52.16 (s, 2C, OMe), 119.83
(s, 4C, CHAr), 124.76 (s, 2C, CAr), 131.09 (s, 4C, CHAr), 158.86 (s,
2C, CArOP), 166.71 (s, 2C, CO). 31P{1H} NMR (162 MHz, 20 °C,
CDCl3): δ 139.9 (bs, 1P). Anal. Calcd for C28H42Br2NiO3P2. C7H8
(847.22): C, 49.62; H, 5.95. Found: C, 49.28; H, 5.89.
6630
dx.doi.org/10.1021/om500938u | Organometallics 2014, 33, 6623−6632